Psychedelic-based therapy shows incredible promise for treating veterans with PTSD
Psychedelic drugs like psilocybin and MDMA have become a very active area of medical research. Psychedelic-based therapy shows great promise in treating disorders ranging from depression and anxiety, to chronic pain and PTSD. One of the populations that could benefit greatly from these treatments is U.S. veterans.
On this episode of River to River, host Ben Kieffer speaks with a Marine Corps veteran who now advocates for psychedelic-based therapy. University of Iowa professor emeritus of psychiatry Dr. Michael Flaum and research scientist Candida Maurer discuss their research into the area and an upcoming clinical trial. And an Iowa lawmaker discusses legislation related to the use of psychedelics.
- Juliana Mercer, Marine Corps veteran, director of veteran advocacy at Healing Breakthrough
- Michael Flaum, MD, professor emeritus of psychiatry with the University of Iowa Hospitals and Clinics
- Candida Maurer, research scientist University of Iowa department of psychiatry in the psychedelic medicine program
- State Rep. Jeff Shipley, R-Birmingham